openPR Logo
Press release

Companion Diagnostic (CD) Market is raised during the forecast period 2013 - 2020

04-07-2021 04:11 PM CET | Health & Medicine

Press release from: Allied Market Research

/ PR Agency: Market Research
According to a new research report by Allied Market Research titled "Global Companion Diagnostic Market (Indications, Technologies and Geography) - Industry Analysis, Trends, Share, Opportunities and Forecast, 2013 - 2020", the global companion diagnostic market is expected to reach $3.5 billion by 2020, and it would grow at a CAGR of 20% from 2014 to 2020. North America was the highest revenue generating region in 2013 and would continue to dominate the market through 2020. Furthermore, LAMEA (Latin America, Middle East and Africa) is expected to be the fastest growing market at a CAGR of 22.7% during the forecast period.

To view the complete report, visit us at http://www.alliedmarketresearch.com/companion-diagnostic-technologies-market

Companion diagnostic (CD) is an in-vitro diagnostic technique that provides information about therapeutic responses of patient to a specific treatment. Companion diagnostics helps in identification of patients who would benefit from the treatment using certain therapeutic product which would result in improved treatment outcomes and decrease expenditure on healthcare.

In addition, CD also helps in identifying the patient pool that is most likely to respond to the therapeutic treatment; therefore, rules out therapies that would be ineffective. Additionally, it also saves patients from adverse side effects due to ineffective therapies, leading to reduced cost. Rising incidence of cancer, increasing adverse reactions due to drugs and personalized treatment approach is pushing R&D efforts to focus on development of targeted therapies. Technological advancement and discovery of new biomarkers is also driving growth of this market.

Request For Customization:- https://www.alliedmarketresearch.com/request-for-customization/135

However, coordinating the development of companion diagnostics and therapeutic products is a challenge for this market. Nevertheless, the increasing incidences of cancer, cardiovascular conditions, central nervous system conditions has resulted in significant investments in research and development of targeted therapies, which would need corresponding companion diagnostics and would be an opportunity for growth of this market.

Companion diagnostics market by indication is segmented into oncology, cardiovascular, CNS, autoimmune & inflammation, virology and others. Presently, majority of the companion diagnostics have been developed for cancer and thus, it is the major revenue generating segment in the overall CD indication market. Companion diagnostics have been developed for breast cancer, lung cancer, colorectal cancer, gastric cancer and melanomas.

Inquiry Before Buying:- https://www.alliedmarketresearch.com/purchase-enquiry/135

Companion diagnostics for breast cancer is the highest revenue generator mainly because there has been an increase in the incidences of breast cancer and many companion diagnostics have been developed for detection of the HER/neu biomarker for breast cancer. As of now, companion diagnostics for cardiovascular conditions, central nervous system conditions , inflammation and autoimmune diseases and viral diseases are very few, with a majority still in development stage; however, as more and more biomarkers are being discovered, there would be an increase in development of new companion diagnostics.

Similar market studies by Allied Market Research -

Global Synthetic Biology Market - http://www.alliedmarketresearch.com/synthetic-biology-market

Global Bioinformatics Market - http://www.alliedmarketresearch.com/bioinformatics-market

Global Tissue Engineering and Regeneration Market - http://www.alliedmarketresearch.com/tissue-engineering-and-regeneration-market

Global Forensic Technologies Market - http://www.alliedmarketresearch.com/forensic-technologies-market

Global Cardiac Biomarkers Market - http://www.alliedmarketresearch.com/cardiac-biomarkers-market

View all Diagnostic and Biotech market studies at - http://www.alliedmarketresearch.com/diagnostic-and-biotech-market-report

Contact:
Sona Padman
5320 SW Macadam Avenue,
Suite 100, Portland, OR 97239
United States
Direct: +1-(617)-674-4143
Toll Free: +1-(855)-711-1555 (U.S. & Canada)
Fax: +1-(855)-550-5975
E-mail: sales@alliedmarketresearch.com
Web: http://www.alliedmarketresearch.com
Blog: http:/blog.alliedmarketresearch.com/
LinkedIn: http://www.linkedin.com/company/allied-market-research

Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions". AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in capturing most accurate market data and confirms utmost accuracy of our market forecasts. Each and every data presented in the reports published by us is also extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Companion Diagnostic (CD) Market is raised during the forecast period 2013 - 2020 here

News-ID: 2267271 • Views:

More Releases from Allied Market Research

Market Size Of Aircraft Brake System Industry is projected to reach $16.95 billion by 2030
Market Size Of Aircraft Brake System Industry is projected to reach $16.95 billi …
Rise in demand from airlines for advanced aircraft brake systems and surge in air passenger traffic offer lucrative opportunities to the global 𝐀𝐢𝐫𝐜𝐫𝐚𝐟𝐭 𝐁𝐫𝐚𝐤𝐞 𝐒𝐲𝐬𝐭𝐞𝐦 𝐌𝐚𝐫𝐤𝐞𝐭. Strict lockdown restrictions and the interruption in the supply chain during the pandemic hindered the market growth for a short period of time. The global aircraft brake system market was valued at $10.52 billion in 2020, and is projected to reach $16.95 billion in
Transportation Infrastructure Market Size is Expected to Surpass US$ 83.3 Billion Through 2031 & CAGR of 7.2| AMR
Transportation Infrastructure Market Size is Expected to Surpass US$ 83.3 Billio …
Growth in demand for highway and railway infrastructure projects along with growing awareness about the importance of effective transportation infrastructure is leading to growth in road, bridge, highway and railway construction activities, which in turn is driving the growth of market . By type, the roads & bridges segment held the highest share in 2021. By region, LAMEA would showcase the fastest CAGR by 2031. Download Sample Report https://www.alliedmarketresearch.com/request-sample/4225 The global transportation infrastructure
Flexible Battery Market Size Expected to Reach $1.5 Billion by 2032 | Samsung SDI Co., Ltd., LG Chem
Flexible Battery Market Size Expected to Reach $1.5 Billion by 2032 | Samsung SD …
Allied Market Research published an exclusive report, titled, "Flexible Battery Market Size, Share, Competitive Landscape and Trend Analysis Report by Type, by Voltage, by Rechargeability, by Application : Global Opportunity Analysis and Industry Forecast, 2023-2032". Global Flexible Battery Market was valued at $0.17 billion in 2022 and is projected to reach $1.5 billion by 2032, growing at a CAGR of 24.9% from 2023 to 2032. Download Research Report Sample & TOC
Asteroid Mining Market Size is projected to reach $3,868.9 million by 2025 | Ispace, Kleos Space S.A., Moon Express
Asteroid Mining Market Size is projected to reach $3,868.9 million by 2025 | Isp …
Allied Market Research published an exclusive report, titled, "Asteroid Mining Market by Phase (Space-craft Design, Launch, and Operation), Asteroid type (Type C, Type S, Type M, and Others), and Application (Construction, Resource Harvesting, 3D Printing, and Others): Global Opportunity Analysis and Industry Forecast, 2017 - 2025". The global asteroid mining market was valued at $712.0 million in 2017 and is projected to reach $3,868.9 million by 2025, growing at a CAGR

All 5 Releases


More Releases for Companion

Companion Animal Drugs - Key Market Statistics
Companion animals are pets kept primarily for company, entertainment, and safety. Owners of companion animals consider them to be family, friends, and confidants. Dogs, cats, birds, rabbits, horses, goats, gerbils, rats, mice, and amphibians, others are considered as companion animals. Read Report Overview - https://www.transparencymarketresearch.com/companion-animal-specialty-drugs-market.html According to the American Society for the Prevention of Cruelty to Animals (ASPCA) defines companion animal to be domesticated or domestically-bred whose emotional, physical, social, and behavioral
Companion Animal Vaccine – Improving The Health Of Companion Animals In A Cost …
The companion animal vaccines market is expected to witness significant growth during the forecast period due to launch of vaccines for companion animals. For instance, in December 2017, Zoetis Inc. announced the launch of Vanguard CIV H3N2/H3N8, the latest vaccine in the company’s canine influenza virus (CIV) portfolio. The new bivalent vaccine helps protect dogs against the two strains of the virus known to be circulating in the U.S. Moreover, the
Companion Diagnostics Market - Easing of Regulatory Policies to Drive Global Dem …
Companion diagnostics include two types of tests namely tests which are developed along with target drugs and the other developed after the commercialization of drugs. Companion diagnostics combined with targeted therapeutics are being seen as a major breakthrough in the personalized medicine field. Companies operating in the companion diagnostics market are seeking an effective growth strategy in the development of this concept drug-diagnostic interaction as the healthcare sector is shifting
Global Companion Diagnostics Market
The Global Companion Diagnostics (CDx) Market was valued at US$ 1,614.5 million in 2015 and is projected to expand at a CAGR of 12.0% during the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights. Development of multiple biomarkers and targeted drug therapy is boosting research and development collaboration among the industry players. This is expected to improve the time to market for companion diagnostic (CDx) test
Global Companion Diagnostics – Growth Companion for Personalized Medicine
Companion Diagnostics: Growth Companion for Personalized Medicine Personalized medicine is the new segment in discussion among healthcare experts around the globe. Also, encouragement from the regulatory bodies such as the FDA and EMEA in erms of providing a defined structure for companion diagnostic development is driving research activities in personalized medicine. Diagnosis at molecular level for each individual is of prime importance to identify the target biomarker before deciding the therapy.
Companion diagnostics Market: Companion diagnostic are used to determine patient …
The few companion diagnostics are already available in the market for specific types of cancer and many are already under clinical development. Companion diagnostics test depends on finding a specific biomarker in the patient and hence biomarker presence or absence determines whether or not the patient will respond to the treatment. This test require a biopsied tissue to access the expression of biomarker protein or mutant or aberrant genes. Companion